Medical Hypotheses · 2020 · 25 citations · 13 references
MedicineInfectious DiseasesOncologyCarcinogenesisInflammationMetastasisInflammatory SignalingLung CancerLung MetastasisOncogenic Signaling PathwaysOncogenic VirusesPulmonary InflammationCarcinogenic PathwaysChronic Inflammatory InjuryHif-1 Alpha RegulationHif-1 SignalingInflammation-driven ProgressionLung Cancer MortalityLung Cancer RiskPulmonary Fibrosis Progression
The morbidity and mortality of lung cancer are increasing. The Corona Virus Disease 2019 (COVID-19) is caused by novel coronavirus 2019-nCoV-2, leading to subsequent pulmonary interstitial fibrosis with chronic inflammatory changes, e.g., inflammatory factors repeatedly continuously stimulating and attacking the alveolar epithelial cells. Meanwhile, 2019-nCoV-2 can activate PI3K/Akt and ERK signaling pathways, which can play the double roles as both anti-inflammatory and carcinogenic factors. Moreover, hypoxemia may be developed, resulting in the up-regulation of HIF-1 α expression, which can be involved in the occurrence, angiogenesis, invasion and metastasis of lung cancer. Additionally, the immune system in 2019-nCoV-2 infected cases can be suppressed to cause tumor immune evasion. Therefore, we speculate that COVID-19 may be a risk factor of secondary lung cancer.
13
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2020 · 21.4K citations · Full text
Phenotype molding of stromal cells in the lung tumor microenvironment
Diether Lambrechts, Els Wauters, Bram Boeckx et al. · Nature Medicine · 2018 · 1.8K citations
Medicine, Cancer Biology, Oncology +16